Global General Influenza Diagnostics Market Growth (Status and Outlook) 2025-2031

September 2025 | 86 pages | ID: G0FD77753D42EN
LP Information

Abstracts

According to this study, the global General Influenza Diagnostics market size will reach US$ million by 2031.

Influenza virus testing is not required to make a clinical diagnosis of Influenza in outpatients with suspected Influenza,Particularly during increased state-run activity when seasonal state-run influenza A and B viruses are circulating in the local community. The traditional detection methods include: RIDT, Viral Culture, DFA, Serological assays.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “General Influenza Diagnostics Industry Forecast” looks at past sales and reviews total world General Influenza Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected General Influenza Diagnostics sales for 2025 through 2031. With General Influenza Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world General Influenza Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global General Influenza Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on General Influenza Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global General Influenza Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for General Influenza Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global General Influenza Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of General Influenza Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• RIDT
• Viral Culture
• DFA
• Serological Assays

Segmentation by Application:

• Hospitals
• Clinical Laboratories
• Other End-User

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• F. Hoffmann-La Roche
• Quidel Corporation
• Thermo Fisher Scientific
• Abbott Laboratories
• Becton, Dickinson, and Company
• DiaSorin
• bioM?rieux

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global General Influenza Diagnostics Market Size (2020-2031)
  2.1.2 General Influenza Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for General Influenza Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 General Influenza Diagnostics Segment by Type
  2.2.1 RIDT
  2.2.2 Viral Culture
  2.2.3 DFA
  2.2.4 Serological Assays
2.3 General Influenza Diagnostics Market Size by Type
  2.3.1 General Influenza Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global General Influenza Diagnostics Market Size Market Share by Type (2020-2025)
2.4 General Influenza Diagnostics Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinical Laboratories
  2.4.3 Other End-User
2.5 General Influenza Diagnostics Market Size by Application
  2.5.1 General Influenza Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global General Influenza Diagnostics Market Size Market Share by Application (2020-2025)

3 GENERAL INFLUENZA DIAGNOSTICS MARKET SIZE BY PLAYER

3.1 General Influenza Diagnostics Market Size Market Share by Player
  3.1.1 Global General Influenza Diagnostics Revenue by Player (2020-2025)
  3.1.2 Global General Influenza Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global General Influenza Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 GENERAL INFLUENZA DIAGNOSTICS BY REGION

4.1 General Influenza Diagnostics Market Size by Region (2020-2025)
4.2 Global General Influenza Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas General Influenza Diagnostics Market Size Growth (2020-2025)
4.4 APAC General Influenza Diagnostics Market Size Growth (2020-2025)
4.5 Europe General Influenza Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa General Influenza Diagnostics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas General Influenza Diagnostics Market Size by Country (2020-2025)
5.2 Americas General Influenza Diagnostics Market Size by Type (2020-2025)
5.3 Americas General Influenza Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC General Influenza Diagnostics Market Size by Region (2020-2025)
6.2 APAC General Influenza Diagnostics Market Size by Type (2020-2025)
6.3 APAC General Influenza Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe General Influenza Diagnostics Market Size by Country (2020-2025)
7.2 Europe General Influenza Diagnostics Market Size by Type (2020-2025)
7.3 Europe General Influenza Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa General Influenza Diagnostics by Region (2020-2025)
8.2 Middle East & Africa General Influenza Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa General Influenza Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL GENERAL INFLUENZA DIAGNOSTICS MARKET FORECAST

10.1 Global General Influenza Diagnostics Forecast by Region (2026-2031)
  10.1.1 Global General Influenza Diagnostics Forecast by Region (2026-2031)
  10.1.2 Americas General Influenza Diagnostics Forecast
  10.1.3 APAC General Influenza Diagnostics Forecast
  10.1.4 Europe General Influenza Diagnostics Forecast
  10.1.5 Middle East & Africa General Influenza Diagnostics Forecast
10.2 Americas General Influenza Diagnostics Forecast by Country (2026-2031)
  10.2.1 United States Market General Influenza Diagnostics Forecast
  10.2.2 Canada Market General Influenza Diagnostics Forecast
  10.2.3 Mexico Market General Influenza Diagnostics Forecast
  10.2.4 Brazil Market General Influenza Diagnostics Forecast
10.3 APAC General Influenza Diagnostics Forecast by Region (2026-2031)
  10.3.1 China General Influenza Diagnostics Market Forecast
  10.3.2 Japan Market General Influenza Diagnostics Forecast
  10.3.3 Korea Market General Influenza Diagnostics Forecast
  10.3.4 Southeast Asia Market General Influenza Diagnostics Forecast
  10.3.5 India Market General Influenza Diagnostics Forecast
  10.3.6 Australia Market General Influenza Diagnostics Forecast
10.4 Europe General Influenza Diagnostics Forecast by Country (2026-2031)
  10.4.1 Germany Market General Influenza Diagnostics Forecast
  10.4.2 France Market General Influenza Diagnostics Forecast
  10.4.3 UK Market General Influenza Diagnostics Forecast
  10.4.4 Italy Market General Influenza Diagnostics Forecast
  10.4.5 Russia Market General Influenza Diagnostics Forecast
10.5 Middle East & Africa General Influenza Diagnostics Forecast by Region (2026-2031)
  10.5.1 Egypt Market General Influenza Diagnostics Forecast
  10.5.2 South Africa Market General Influenza Diagnostics Forecast
  10.5.3 Israel Market General Influenza Diagnostics Forecast
  10.5.4 Turkey Market General Influenza Diagnostics Forecast
10.6 Global General Influenza Diagnostics Forecast by Type (2026-2031)
10.7 Global General Influenza Diagnostics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market General Influenza Diagnostics Forecast

11 KEY PLAYERS ANALYSIS

11.1 F. Hoffmann-La Roche
  11.1.1 F. Hoffmann-La Roche Company Information
  11.1.2 F. Hoffmann-La Roche General Influenza Diagnostics Product Offered
  11.1.3 F. Hoffmann-La Roche General Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 F. Hoffmann-La Roche Main Business Overview
  11.1.5 F. Hoffmann-La Roche Latest Developments
11.2 Quidel Corporation
  11.2.1 Quidel Corporation Company Information
  11.2.2 Quidel Corporation General Influenza Diagnostics Product Offered
  11.2.3 Quidel Corporation General Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Quidel Corporation Main Business Overview
  11.2.5 Quidel Corporation Latest Developments
11.3 Thermo Fisher Scientific
  11.3.1 Thermo Fisher Scientific Company Information
  11.3.2 Thermo Fisher Scientific General Influenza Diagnostics Product Offered
  11.3.3 Thermo Fisher Scientific General Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Thermo Fisher Scientific Main Business Overview
  11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Abbott Laboratories
  11.4.1 Abbott Laboratories Company Information
  11.4.2 Abbott Laboratories General Influenza Diagnostics Product Offered
  11.4.3 Abbott Laboratories General Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Abbott Laboratories Main Business Overview
  11.4.5 Abbott Laboratories Latest Developments
11.5 Becton, Dickinson, and Company
  11.5.1 Becton, Dickinson, and Company Company Information
  11.5.2 Becton, Dickinson, and Company General Influenza Diagnostics Product Offered
  11.5.3 Becton, Dickinson, and Company General Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Becton, Dickinson, and Company Main Business Overview
  11.5.5 Becton, Dickinson, and Company Latest Developments
11.6 DiaSorin
  11.6.1 DiaSorin Company Information
  11.6.2 DiaSorin General Influenza Diagnostics Product Offered
  11.6.3 DiaSorin General Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 DiaSorin Main Business Overview
  11.6.5 DiaSorin Latest Developments
11.7 bioM?rieux
  11.7.1 bioM?rieux Company Information
  11.7.2 bioM?rieux General Influenza Diagnostics Product Offered
  11.7.3 bioM?rieux General Influenza Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 bioM?rieux Main Business Overview
  11.7.5 bioM?rieux Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. General Influenza Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. General Influenza Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of RIDT
Table 4. Major Players of Viral Culture
Table 5. Major Players of DFA
Table 6. Major Players of Serological Assays
Table 7. General Influenza Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global General Influenza Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 9. Global General Influenza Diagnostics Market Size Market Share by Type (2020-2025)
Table 10. General Influenza Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global General Influenza Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 12. Global General Influenza Diagnostics Market Size Market Share by Application (2020-2025)
Table 13. Global General Influenza Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 14. Global General Influenza Diagnostics Revenue Market Share by Player (2020-2025)
Table 15. General Influenza Diagnostics Key Players Head office and Products Offered
Table 16. General Influenza Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global General Influenza Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 20. Global General Influenza Diagnostics Market Size Market Share by Region (2020-2025)
Table 21. Global General Influenza Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global General Influenza Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas General Influenza Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas General Influenza Diagnostics Market Size Market Share by Country (2020-2025)
Table 25. Americas General Influenza Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas General Influenza Diagnostics Market Size Market Share by Type (2020-2025)
Table 27. Americas General Influenza Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas General Influenza Diagnostics Market Size Market Share by Application (2020-2025)
Table 29. APAC General Influenza Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC General Influenza Diagnostics Market Size Market Share by Region (2020-2025)
Table 31. APAC General Influenza Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC General Influenza Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe General Influenza Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe General Influenza Diagnostics Market Size Market Share by Country (2020-2025)
Table 35. Europe General Influenza Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe General Influenza Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa General Influenza Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa General Influenza Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa General Influenza Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of General Influenza Diagnostics
Table 41. Key Market Challenges & Risks of General Influenza Diagnostics
Table 42. Key Industry Trends of General Influenza Diagnostics
Table 43. Global General Influenza Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global General Influenza Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global General Influenza Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global General Influenza Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. F. Hoffmann-La Roche Details, Company Type, General Influenza Diagnostics Area Served and Its Competitors
Table 48. F. Hoffmann-La Roche General Influenza Diagnostics Product Offered
Table 49. F. Hoffmann-La Roche General Influenza Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. F. Hoffmann-La Roche Main Business
Table 51. F. Hoffmann-La Roche Latest Developments
Table 52. Quidel Corporation Details, Company Type, General Influenza Diagnostics Area Served and Its Competitors
Table 53. Quidel Corporation General Influenza Diagnostics Product Offered
Table 54. Quidel Corporation General Influenza Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Quidel Corporation Main Business
Table 56. Quidel Corporation Latest Developments
Table 57. Thermo Fisher Scientific Details, Company Type, General Influenza Diagnostics Area Served and Its Competitors
Table 58. Thermo Fisher Scientific General Influenza Diagnostics Product Offered
Table 59. Thermo Fisher Scientific General Influenza Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Thermo Fisher Scientific Main Business
Table 61. Thermo Fisher Scientific Latest Developments
Table 62. Abbott Laboratories Details, Company Type, General Influenza Diagnostics Area Served and Its Competitors
Table 63. Abbott Laboratories General Influenza Diagnostics Product Offered
Table 64. Abbott Laboratories General Influenza Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Abbott Laboratories Main Business
Table 66. Abbott Laboratories Latest Developments
Table 67. Becton, Dickinson, and Company Details, Company Type, General Influenza Diagnostics Area Served and Its Competitors
Table 68. Becton, Dickinson, and Company General Influenza Diagnostics Product Offered
Table 69. Becton, Dickinson, and Company General Influenza Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Becton, Dickinson, and Company Main Business
Table 71. Becton, Dickinson, and Company Latest Developments
Table 72. DiaSorin Details, Company Type, General Influenza Diagnostics Area Served and Its Competitors
Table 73. DiaSorin General Influenza Diagnostics Product Offered
Table 74. DiaSorin General Influenza Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. DiaSorin Main Business
Table 76. DiaSorin Latest Developments
Table 77. bioM?rieux Details, Company Type, General Influenza Diagnostics Area Served and Its Competitors
Table 78. bioM?rieux General Influenza Diagnostics Product Offered
Table 79. bioM?rieux General Influenza Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. bioM?rieux Main Business
Table 81. bioM?rieux Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. General Influenza Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global General Influenza Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. General Influenza Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. General Influenza Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. General Influenza Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global General Influenza Diagnostics Market Size Market Share by Type in 2024
Figure 10. General Influenza Diagnostics in Hospitals
Figure 11. Global General Influenza Diagnostics Market: Hospitals (2020-2025) & ($ millions)
Figure 12. General Influenza Diagnostics in Clinical Laboratories
Figure 13. Global General Influenza Diagnostics Market: Clinical Laboratories (2020-2025) & ($ millions)
Figure 14. General Influenza Diagnostics in Other End-User
Figure 15. Global General Influenza Diagnostics Market: Other End-User (2020-2025) & ($ millions)
Figure 16. Global General Influenza Diagnostics Market Size Market Share by Application in 2024
Figure 17. Global General Influenza Diagnostics Revenue Market Share by Player in 2024
Figure 18. Global General Influenza Diagnostics Market Size Market Share by Region (2020-2025)
Figure 19. Americas General Influenza Diagnostics Market Size 2020-2025 ($ millions)
Figure 20. APAC General Influenza Diagnostics Market Size 2020-2025 ($ millions)
Figure 21. Europe General Influenza Diagnostics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa General Influenza Diagnostics Market Size 2020-2025 ($ millions)
Figure 23. Americas General Influenza Diagnostics Value Market Share by Country in 2024
Figure 24. United States General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC General Influenza Diagnostics Market Size Market Share by Region in 2024
Figure 29. APAC General Influenza Diagnostics Market Size Market Share by Type (2020-2025)
Figure 30. APAC General Influenza Diagnostics Market Size Market Share by Application (2020-2025)
Figure 31. China General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 35. India General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe General Influenza Diagnostics Market Size Market Share by Country in 2024
Figure 38. Europe General Influenza Diagnostics Market Size Market Share by Type (2020-2025)
Figure 39. Europe General Influenza Diagnostics Market Size Market Share by Application (2020-2025)
Figure 40. Germany General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 41. France General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa General Influenza Diagnostics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa General Influenza Diagnostics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa General Influenza Diagnostics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries General Influenza Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 54. APAC General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 55. Europe General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 57. United States General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 58. Canada General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 59. Mexico General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 60. Brazil General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 61. China General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 62. Japan General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 63. Korea General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. India General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. Australia General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. Germany General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. France General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. UK General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. Italy General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. Russia General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. Egypt General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. South Africa General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Israel General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 75. Turkey General Influenza Diagnostics Market Size 2026-2031 ($ millions)
Figure 76. Global General Influenza Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global General Influenza Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries General Influenza Diagnostics Market Size 2026-2031 ($ millions)